Carbonic anhydrase (CA) inhibitors hold significant promise across diverse therapeutic domains owing to their multifaceted mechanism of action. This paper delves into their therapeutic applications, h
To get a better understanding of the possibility of developing selective carbonic anhydrase (CA) inhibitors, interactions between 17 benzenesulphonamide ligands and 6 human CAs (full-length CA I, II,
Crystal structure of human carbonic anhydrase isozyme II with 4-(1H-benzimidazol-1-ylacetyl)benzenesulfonamide Descriptor: 4-[2-(benzimidazol-1-yl)ethanoyl]benzenesulfonamide, BICINE, Carbonic anhydra
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects Descriptor: 2-(2,4-dioxo-1,3-diazaspir
Closo-carborane propyl-sulfonamide in complex with CA II Descriptor: Carbonic anhydrase 2, Carborane propyl-sulfonamide, ZINC ION Authors: Kugler, M, Brynda, J, Pospisilova, K, Rezacova, P. Deposit da
